Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Progress in Orthodontics
|
October 27, 2010
A simple and efficient procedure for indirect bonding
Raffaello Cortesi, Lia Molinari
Leukemia & Lymphoma
|
October 1, 2005
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy
Pier Luigi Zinzani, Monica Tani, Lapo Alinari, et al.
Haematologica
|
August 6, 2002
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients
Pier Luigi Zinzani, Monica Tani, Anna Lia Molinari, et al.
Haematologica
|
May 15, 2003
B-cell compartment as the selective target for the treatment of immune thrombocytopenias
Francesco Zaja, Nicola Vianelli, Alessandra Sperotto, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
June 25, 2013
Lenalidomide in combination with dexamethasone in elderly patients with advanced, relapsed or refractory multiple myeloma and renal failure
Patrizia Tosi, Barbara Gamberi, Barbara Castagnari, et al.
Leukemia & Lymphoma
|
June 30, 2004
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma
Pier Luigi Zinzani, Alessandro Pulsoni, Patrizia Gentilini, et al.
Journal of Geriatric Oncology
|
July 13, 2019
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi
Francesco Merli, Federica Cavallo, Flavia Salvi, et al.
Annals of Hematology
|
December 25, 2019
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments
Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, et al.
Haematologica
|
February 10, 2016
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi
Stefano Sacchi, Raffaella Marcheselli, Alessia Bari, et al.
Annals of Hematology
|
November 21, 2020
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments
Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Progress in Orthodontics
|
October 27, 2010
A simple and efficient procedure for indirect bonding
Raffaello Cortesi, Lia Molinari
Leukemia & Lymphoma
|
October 1, 2005
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy
Pier Luigi Zinzani, Monica Tani, Lapo Alinari, et al.
Haematologica
|
August 6, 2002
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients
Pier Luigi Zinzani, Monica Tani, Anna Lia Molinari, et al.
Haematologica
|
May 15, 2003
B-cell compartment as the selective target for the treatment of immune thrombocytopenias
Francesco Zaja, Nicola Vianelli, Alessandra Sperotto, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
June 25, 2013
Lenalidomide in combination with dexamethasone in elderly patients with advanced, relapsed or refractory multiple myeloma and renal failure
Patrizia Tosi, Barbara Gamberi, Barbara Castagnari, et al.
Leukemia & Lymphoma
|
June 30, 2004
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma
Pier Luigi Zinzani, Alessandro Pulsoni, Patrizia Gentilini, et al.
Journal of Geriatric Oncology
|
July 13, 2019
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi
Francesco Merli, Federica Cavallo, Flavia Salvi, et al.
Annals of Hematology
|
December 25, 2019
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments
Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, et al.
Haematologica
|
February 10, 2016
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi
Stefano Sacchi, Raffaella Marcheselli, Alessia Bari, et al.
Annals of Hematology
|
November 21, 2020
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments
Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, et al.
Page
of 2